PROM1 and neoplasm: The flow cytometry analyses showed 92.1% cells expressing GFAP, a tumor glial marker, of which 52.5% double stained for CD133 and 71% cells expressing Nestin, an immature neural stem cell marker, of which 44.8% double stained for CD133.